I'm concerned the CD12 trial won't be enough for FDA to approve EUA because the only measurement being counted is mortality. Nothing for viral load suppression, oxy saturation, or anything else. Does this concern you as well?
I have to say it is interesting seeing you go short term bearish at the same time Grip is going bullish and buying back in (at least I think I saw a post to that affect). I’m not sure what all of that means other than we find ourselves in uncertain times in regards to events in the next several months.